Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01367938 · ClinicalTrials.gov registry record

Clinical Outcomes With Omni Apex Ultracongruent Knee System

A clinical trial of Osteoarthritis, Knee, sponsored by Spokane Joint Replacement Center.

Completed
Registry status
69
Enrollment target
1
Study location

NCT01367938: Completed study of Osteoarthritis, Knee, sponsored by Spokane Joint Replacement Center.

NCT01367938 is a study of Osteoarthritis, Knee that has completed, run by Spokane Joint Replacement Center. The registered enrollment target is 69 participants, below the 497-participant average among 112 other Osteoarthritis, Knee trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01367938, a study of Osteoarthritis, Knee, has completed, sponsored by Spokane Joint Replacement Center.

COMPLETED
Registry status
69 participants
Enrollment target
1
Study location

Study Summary

A prospective, matched case comparison of total knee arthroplasty with the OMNI Apex Ultracongruent vs. Triathlon® CS tibial insert vs. the Triathlon® PS tibial insert.

Primary Outcome

Clinical outcomes to include overall success, revision rate, adverse events, clinical score (Knee Society Score), range of motion, radiographic findings.

Conditions Studied

Interventions

  • DEVICE OMNI Apex Ultracongruent Knee Device

Study Locations (1)

Washington

  • Spokane Joint Replacement Center - Spokane

Trial Details

FieldValue
Enrollment Target 69 participants
Start Date 2009-11
Est. Completion 2018-12
Spokane Joint Replacement Center

5 total trials

What the finished NCT01367938 record still lists

NCT01367938 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 69 participants, a relatively small participant target, below the 497-participant average among 112 other Osteoarthritis, Knee trials with a reported enrollment target (86% lower).

The record links to 1 condition, with Osteoarthritis, Knee appearing as the primary indexed condition, and to 1 intervention - of which OMNI Apex Ultracongruent Knee Device is the first listed.

NCT01367938 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT01367938 about?

NCT01367938 is a clinical study titled "Clinical Outcomes With Omni Apex Ultracongruent Knee System". A prospective, matched case comparison of total knee arthroplasty with the OMNI Apex Ultracongruent vs. Triathlon® CS tibial insert vs. the Triathlon® PS tibial insert.

What is the current status of trial NCT01367938?

This trial is currently completed. The enrollment target is 69 participants. The study started on 2009-11. Estimated completion is 2018-12.

What conditions does trial NCT01367938 study?

This clinical trial studies the following conditions: Osteoarthritis, Knee.

What interventions are being tested in trial NCT01367938?

The interventions under investigation include: OMNI Apex Ultracongruent Knee Device (DEVICE).

Who is sponsoring clinical trial NCT01367938?

This trial is sponsored by Spokane Joint Replacement Center, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01367938 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteoarthritis, Knee

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01367938's enrollment target sits among peer trials

69 81st of 112 higher than 32 of 112 other Osteoarthritis, Knee trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Osteoarthritis, Knee trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04020575 · 69 participants · Phase 1

    Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)

  • NCT04163614 · 69 participants · NA

    Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients

  • NCT04164641 · 69 participants · NA

    Noraxon myoRESEARCH™ Software Gait Analysis Evaluation and Orthotic Gait Correction in Reducing Diabetic Foot Ulceration Or Subsequent Amputation in Patients With a History of a Diabetic Foot Ulceration

  • NCT04493372 · 69 participants · NA

    Deciphering Preserved Autonomic Function After Spinal Cord Injury

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01367938, the US trial registry maintained by the National Library of Medicine. NCT01367938 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.